Kopran Limited (NSE:KOPRAN)

Market Cap	8.80B
Revenue (ttm)	6.25B
Net Income (ttm)	349.06M
Shares Out	n/a
EPS (ttm)	7.23
PE Ratio	25.21
Forward PE	n/a
Dividend	3.00 (1.64%)
Ex-Dividend Date	Sep 4, 2025

Volume	169,823
Average Volume	278,321
Open	185.00
Previous Close	184.76
Day's Range	181.10 - 186.90
52-Week Range	154.06 - 369.70
Beta	0.28
RSI	70.95
Earnings Date	Aug 8, 2025

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1958
• Employees: 1,024
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: KOPRAN

Financial Performance

In 2024, Kopran's revenue was 6.30 billion, an increase of 2.44% compared to the previous year's 6.15 billion. Earnings were 385.52 million, a decrease of -24.34%.